Carol S. Lim

6.1k total citations · 1 hit paper
72 papers, 2.1k citations indexed

About

Carol S. Lim is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Carol S. Lim has authored 72 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 16 papers in Oncology and 15 papers in Genetics. Recurrent topics in Carol S. Lim's work include Chronic Myeloid Leukemia Treatments (13 papers), Cancer-related Molecular Pathways (12 papers) and RNA Interference and Gene Delivery (10 papers). Carol S. Lim is often cited by papers focused on Chronic Myeloid Leukemia Treatments (13 papers), Cancer-related Molecular Pathways (12 papers) and RNA Interference and Gene Delivery (10 papers). Carol S. Lim collaborates with scholars based in United States, Germany and South Korea. Carol S. Lim's co-authors include Benjamin Bruno, Geoffrey D. Miller, Gordon L. Hager, Christopher T. Baumann, Jonathan E. Constance, Andrew S. Dixon, David W. Woessner, Cem Elbi, Han Htun and Catharine L. Smith and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Carol S. Lim

68 papers receiving 2.0k citations

Hit Papers

Basics and Recent Advances in Peptide and Protein Drug De... 2013 2026 2017 2021 2013 100 200 300 400 500

Peers

Carol S. Lim
Cy A. Stein United States
Sergei Gryaznov United States
Philip R. Dash United Kingdom
Tracie Delgado United States
John C. Voyta United States
Rudolph L. Juliano United States
Carol S. Lim
Citations per year, relative to Carol S. Lim Carol S. Lim (= 1×) peers Volker Schellenberger

Countries citing papers authored by Carol S. Lim

Since Specialization
Citations

This map shows the geographic impact of Carol S. Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol S. Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol S. Lim more than expected).

Fields of papers citing papers by Carol S. Lim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol S. Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol S. Lim. The network helps show where Carol S. Lim may publish in the future.

Co-authorship network of co-authors of Carol S. Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Carol S. Lim. A scholar is included among the top collaborators of Carol S. Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol S. Lim. Carol S. Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lima, Maria Carolina P., et al.. (2024). Molecular Modeling of Single- and Double-Hydrocarbon-Stapled Coiled-Coil Inhibitors against Bcr-Abl: Toward a Treatment Strategy for CML. The Journal of Physical Chemistry B. 128(27). 6476–6491. 2 indexed citations
2.
Lim, Carol S., et al.. (2023). The Challenges and Prospects of p53-Based Therapies in Ovarian Cancer. Biomolecules. 13(1). 159–159. 31 indexed citations
3.
Mause, Erica R. Vander, Jillian M. Baker, Sabarinath Venniyil Radhakrishnan, et al.. (2023). Systematic single amino acid affinity tuning of CD229 CAR T cells retains efficacy against multiple myeloma and eliminates on-target off-tumor toxicity. Science Translational Medicine. 15(705). eadd7900–eadd7900. 17 indexed citations
4.
Constance, Jonathan E., Mary McFarland, Michael W. Deininger, et al.. (2023). Mapping the Evidence for Opioid-Mediated Changes in Malignancy and Chemotherapeutic Efficacy: Protocol for a Scoping Review. JMIR Research Protocols. 12. e38167–e38167. 1 indexed citations
5.
Mause, Erica R. Vander, Djordje Atanackovic, Carol S. Lim, & Tim Luetkens. (2022). Roadmap to affinity-tuned antibodies for enhanced chimeric antigen receptor T cell function and selectivity. Trends in biotechnology. 40(7). 875–890. 25 indexed citations
6.
Lim, Carol S., et al.. (2021). Attitudes and Beliefs on Aging Among Middle-Aged and Older Adults With Serious Mental Illness. American Journal of Geriatric Psychiatry. 30(3). 419–423. 1 indexed citations
7.
Mause, Erica R. Vander, et al.. (2019). Mitochondrially targeted p53 or DBD subdomain is superior to wild type p53 in ovarian cancer cells even with strong dominant negative mutant p53. Journal of Ovarian Research. 12(1). 45–45. 7 indexed citations
8.
Wang, Yuanxiang, Benjamin Bruno, Chen Diao, et al.. (2017). Application of Thiol–yne/Thiol–ene Reactions for Peptide and Protein Macrocyclizations. Chemistry - A European Journal. 23(29). 7087–7092. 43 indexed citations
9.
Bruno, Benjamin, et al.. (2015). Delivery of drugs and macromolecules to the mitochondria for cancer therapy. Journal of Controlled Release. 240. 38–51. 108 indexed citations
10.
Constance, Jonathan E., et al.. (2012). Selective Targeting of c-Abl via a Cryptic Mitochondrial Targeting Signal Activated by Cellular Redox Status in Leukemic and Breast Cancer Cells. Pharmaceutical Research. 29(8). 2317–2328. 9 indexed citations
11.
Lim, Carol S., et al.. (2012). Utilizing the Estrogen Receptor Ligand-Binding Domain for Controlled Protein Translocation to the Insoluble Fraction. Pharmaceutical Research. 29(12). 3455–3463. 4 indexed citations
12.
Dixon, Andrew S., Jonathan E. Constance, Tomoyuki Tanaka, Terence H. Rabbitts, & Carol S. Lim. (2011). Changing the Subcellular Location of the Oncoprotein Bcr-Abl Using Rationally Designed Capture Motifs. Pharmaceutical Research. 29(4). 1098–1109. 13 indexed citations
13.
Cadwallader, Amy B., Carol S. Lim, Douglas E. Rollins, & Francesco Botrè. (2011). The Androgen Receptor and Its Use in Biological Assays: Looking Toward Effect-Based Testing and Its Applications. Journal of Analytical Toxicology. 35(9). 594–607. 20 indexed citations
14.
Woessner, David W., Carol S. Lim, & Michael W. Deininger. (2011). Development of an Effective Therapy for Chronic Myelogenous Leukemia. The Cancer Journal. 17(6). 477–486. 33 indexed citations
15.
Gan, Boyi, Carol S. Lim, Gerald Chu, et al.. (2010). FoxOs Enforce a Progression Checkpoint to Constrain mTORC1-Activated Renal Tumorigenesis. Cancer Cell. 18(5). 472–484. 116 indexed citations
16.
Dixon, Andrew S., et al.. (2009). Controlling subcellular localization to alter function: Sending oncogenic Bcr–Abl to the nucleus causes apoptosis. Journal of Controlled Release. 140(3). 245–249. 20 indexed citations
17.
Kern, Steven E., et al.. (2007). Optimizing the protein switch: Altering nuclear import and export signals, and ligand binding domain. Journal of Controlled Release. 120(3). 220–232. 19 indexed citations
18.
Yan, Guang, et al.. (2003). Correlation Among Agonist Dose, Rate of Import, and Transcriptional Activity of Liganded Progesterone Receptor B Isoform in Living Cells. Pharmaceutical Research. 20(10). 1574–1580. 6 indexed citations
19.
Li, Henan, et al.. (2002). Model system to study classical nuclear export signals. PubMed. 4(3). 61–68. 23 indexed citations
20.
Baumann, Christopher T., Carol S. Lim, & Gordon L. Hager. (1999). Intracellular localization and trafficking of steroid receptors. Cell Biochemistry and Biophysics. 31(2). 119–127. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026